Marta Marin-Argany
Overview
Explore the profile of Marta Marin-Argany including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eftekharzadeh B, Banduseela V, Chiesa G, Martinez-Cristobal P, Rauch J, Nath S, et al.
Nat Commun
. 2019 Oct;
10(1):4605.
PMID: 31591399
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
2.
Eftekharzadeh B, Banduseela V, Chiesa G, Martinez-Cristobal P, Rauch J, Nath S, et al.
Nat Commun
. 2019 Aug;
10(1):3562.
PMID: 31395886
Molecular chaperones such as Hsp40 and Hsp70 hold the androgen receptor (AR) in an inactive conformation. They are released in the presence of androgens, enabling transactivation and causing the receptor...
3.
Blancas-Mejia L, Misra P, Dick C, Marin-Argany M, Redhage K, Cooper S, et al.
Methods Mol Biol
. 2018 Oct;
1873:123-153.
PMID: 30341607
Common biophysical techniques like absorption and fluorescence spectroscopy, microscopy, and light scattering studies have been in use to investigate fibril assembly for a long time. However, there is sometimes a...
4.
Lin Y, Marin-Argany M, Dick C, Redhage K, Blancas-Mejia L, Bulur P, et al.
Cytotherapy
. 2017 Oct;
19(12):1426-1437.
PMID: 29037943
Background Aims: Light chain (AL) amyloidosis is a protein misfolding disease characterized by extracellular deposition of immunoglobulin light chains (LC) as amyloid fibrils. Patients with LC amyloid involvement of the...
5.
Ramirez-Alvarado M, Barnidge D, Murray D, Dispenzieri A, Marin-Argany M, Dick C, et al.
Am J Hematol
. 2017 Mar;
92(6):536-541.
PMID: 28295502
Immunoglobulin light chain (AL) amyloidosis is a fatal complication of B-cell proliferation secondary to deposition of amyloid fibrils in various organs. Urinary exosomes (UEX) are the smallest of the microvesicles...
6.
Marin-Argany M, Lin Y, Misra P, Williams A, Wall J, Howell K, et al.
J Biol Chem
. 2016 Jul;
291(38):19813-25.
PMID: 27462073
Light chain (AL) amyloidosis is an incurable human disease characterized by the misfolding, aggregation, and systemic deposition of amyloid composed of immunoglobulin light chains (LC). This work describes our studies...
7.
Marin-Argany M, Guell-Bosch J, Blancas-Mejia L, Villegas S, Ramirez-Alvarado M
Protein Sci
. 2015 Aug;
24(11):1829-40.
PMID: 26300552
Light chain (AL) amyloidosis is an incurable human disease, where the amyloid precursor is a misfolding-prone immunoglobulin light-chain. Here, we identify the role of somatic mutations in the structure, stability...
8.
Blancas-Mejia L, Horn T, Marin-Argany M, Auton M, Tischer A, Ramirez-Alvarado M
Biophys Chem
. 2015 Aug;
207:13-20.
PMID: 26263488
Light chain (AL) amyloidosis is a fatal disease where monoclonal immunoglobulin light chains deposit as insoluble amyloid fibrils. For many years it has been considered that AL amyloid deposits are...
9.
Blancas-Mejia L, Hammernik J, Marin-Argany M, Ramirez-Alvarado M
J Biol Chem
. 2014 Dec;
290(8):4953-4965.
PMID: 25538238
Amyloid light chain (AL) amyloidosis is a protein misfolding disease where immunoglobulin light chains sample partially folded states that lead to misfolding and amyloid formation, resulting in organ dysfunction and...
10.
Murciano-Calles J, Marin-Argany M, Cobos E, Villegas S, Martinez J
PLoS One
. 2014 May;
9(5):e98124.
PMID: 24845085
The modulation of binding affinities and specificities by post-translational modifications located out from the binding pocket of the third PDZ domain of PSD-95 (PDZ3) has been reported recently. It is...